在子宫内膜癌中,TERT促进器突变和基因放大
Aaron M Praiss1, Antonio Marra2, Qin Zhou3
1Gynecology Service, Departments of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
带有端粒酶逆转录酶 (TERT) 改变的子宫内膜癌 (ECs),虽然很少见,但与特定的分子亚型和明显更差的生存结果有关. 识别TERT改变的EC对于了解疾病进展和改善患者预后至关重要.
科学领域:
- 妇科瘤学 妇科瘤学
- 癌症基因组学 癌症基因组学
- 分子病理学分子病理学
背景情况:
- 子宫内膜癌 (ECs) 占妇科恶性瘤的很大一部分.
- 端粒酶逆转录酶 (TERT) 突变和放大越来越多地被认为是各种癌症中重要的分子驱动因素.
- 了解TERT改变的ECs的临床病理和分子格局对于准确的诊断和治疗分层是必不可少的.
研究的目的:
- 为了研究子宫内膜癌 (ECs) 的临床病理特征,分子概况和生存结果,与端粒酶逆转录酶 (TERT) 热点突变或基因放大.
- 为了比较TERT改变的EC与TERT野生型EC的特征.
主要方法:
- 1944年经过临床瘤正常测序的EC病例的回顾性分析.
- 具有体质TERT促进体热点突变或基因放大 (TERT-改变) 的ECs的识别和特征.
- 对TERT变异和TERT野生型EC队列的临床病理变量,体质突变概况和生存数据的评估.
主要成果:
- 66个TERT改变的EC (3%的病例) 被确定,包括TERT变异和TERT放大亚型.
- 有关TERT变化的EC与复制数 (CN) 高/TP53异常 (TP53abn) 分子类型,血清组织学以及TP53,CDKN2A/B和DROSHA突变的丰富显著相关.
- 与TERT野生型EC相比,TERT改变的EC患者的中位数无进展生存时间 (18.7个月) 和总生存时间 (46.7个月) 显着较短.
结论:
- TERT-改变的ECs虽然不常见,但具有特定的分子特征,包括CN-高/TP53abn状态和TP53,CDKN2A/B和DROSHA的改变.
- TERT变化状态独立预测子宫内膜癌患者的生存结果更差.
- 这些发现强调了TERT变化的重要性,作为EC中的预后生物标志物.
更多相关视频
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
相关概念视频
Mitogens and the Cell Cycle
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
